Breast cancer patients who lack RB gene respond better to neoadjuvant chemotherapy
Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University Hospital and the Kimmel ...
Jul 26, 2012
0
0